Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James F. Tessmer currently holds 83,766 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James F. Tessmer has been a net seller of LXRX stock. They have purchased $11.4K and sold $388.1K worth of shares.
James F. Tessmer's most recent insider trade was on Mar 15, 2021, when they sold 12,000 shares at $3.31 per share.
James F. Tessmer serves as Executive at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have executed 63 insider transactions totaling $399.5K over their tenure at the company.
James F. Tessmer holds the position of Executive at LEXICON PHARMACEUTICALS, INC./DE, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
James F. Tessmer has shown a selling trading pattern, with $11.4K in total purchases and $388.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James F. Tessmer was on Jun 8, 2018, when they sold $129.1K worth of LXRX shares. This transaction involved 10,000 shares at $12.91 per share.
James F. Tessmer currently owns 83,766 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James F. Tessmer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James F. Tessmer has 63 Form 4 filings on record as an insider at LEXICON PHARMACEUTICALS, INC./DE.
Set alerts for James F. Tessmer and 40,000+ other insiders.